Abstract: This article presents a subharmonic injection-locked clock multiplier (SILCM) with low rms jitter and low reference spur. To improve rms jitter while suppressing reference spur, reference ...

The latest update is out from Dyadic International ( (DYAI)). On December 23, 2025, Dyadic International, Inc. amended its Senior Secured Convertible Promissory Notes due March 8, 2027, extending ...

Dyadic Applied BioSolutions expanded its collaboration with Fermbox Bio, a biotech research & manufacturing company developing and delivering bio-based products through precision fermentation and ...

Good evening, and welcome to Dyadic International's Q3 2025 Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, November 12, 2025. I would now like to ...

The hidden toll: Social isolation and affordability barriers among cancer caregivers. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium. This abstract does not include a full ...

Dyadic International, Inc. (NASDAQ:DYAI) Q2 2025 Earnings Call Transcript August 13, 2025 Dyadic International, Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations ...

Abstract: Dyadic regression models, which output real-valued predictions for pairs of entities, are fundamental in many domains [e.g., obtaining user-product ratings in recommender systems (RSs)] and ...

Reflects the Company’s strategic focus on commercializing non-therapeutic proteins and unlocking long-term value from its C1 and Dapibus™ gene expression platforms JUPITER, Fla.--(BUSINESS WIRE)-- ...

Researchers demonstrate a novel method for transforming continuous time crystals into discrete ones using subharmonic injection locking, offering new insights into symmetry breaking and control in ...

Dyadic International, Inc. has announced a leadership change, appointing Joe Hazelton as President to enhance its strategy of focusing on ancillary recombinant protein products for life sciences, ...

Rapid commercial validation has been achieved through key partnerships disrupting high value/high growth markets Leadership team realigned in order to enable execution of ancillary protein strategy ...